Impact of Antibody Affinity and Antigen Density on Tumor Cell Killing
Author Information
Author(s): MP Velders, CM van Rhijn, E Oskam, GJ Fleuren, SO Warnaar, SV Litvinov
Primary Institution: Leiden University
Hypothesis
How do antibody affinity and antigen density affect antibody-dependent cellular cytotoxicity (ADCC) in tumor cells?
Conclusion
High-affinity antibodies can effectively kill tumor cells with low antigen expression levels, improving immunotherapy outcomes.
Supporting Evidence
- The high-affinity MAb 323/A3 was more effective than the low-affinity MAb 17-1A in mediating tumor cell killing.
- ADCC efficacy was influenced by both antibody affinity and antigen density.
- Cells with higher levels of Ep-CAM were lysed more efficiently than those with lower levels.
Takeaway
This study shows that stronger antibodies can kill more cancer cells, even if those cells don't have a lot of the target they need to be killed.
Methodology
In vitro experiments comparing the effects of low-affinity and high-affinity monoclonal antibodies on tumor cells with varying antigen expression.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Want to read the original?
Access the complete publication on the publisher's website